Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
10.1093/nar/gkz072 Nucleic Acids Res
Clinically meaningful responses in insulin-resistant patients typically include a reduction in fasting insulin of 20-40% and an improvement in HOMA-IR within 8-12 weeks at therapeutic doses, though individual variability is wide [1]
[47] presented latest results at American Society of Clinical Oncology (ASCO) 2024, with Dato-DXd showing similar efficacy and safety data to that reported in TROPION-Lung01
DOI: 10.1530/eje.0.1390552 Ankersen M, Johansen NL, Madsen K, Hansen BS, Raun K, Nielsen KK, et al
AZD6244 and doxorubicin induce growth suppression and apoptosis in mouse models of hepatocellular carcinoma
US$ 23.98
US$ 21.35
US$ 25.33
US$ 26.04
US$ 25.91
